- Is percutaneous computed tomography-guided biopsy sufficient to establish indolent lymphoma transformation?2019 | Faculty of Medicine in Hradec Králové
- The induction of molecular genetic conversion in bone marrow (BM) in Patients with indolent Lymphomas Treated by Mnoclonal Antibody anti-CD20 (MABTHERA)Publication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: C-5013-NHL-007Publication without faculty affiliation
- Unusual Sequence of VDJ Rearrangement Revealed by Molecular Analysis in a Patient with Indolent Lymphoma2003 | First Faculty of Medicine
- AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma2019 | First Faculty of Medicine
- Obinutuzumab in the treatment of non-Hodgkin's B-cell lymphoma - GADOLIN trial2015 | Faculty of Medicine in Hradec Králové
- Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study2016 | Publication without faculty affiliation
- Maintenance therapy with rituximab for non-Hodgkin's lymphoma - opportunities in 20102010 | Faculty of Medicine in Hradec Králové
- Recommendations for screening, diagnosis, prophylaxis and treatment of hepatitis in haemato-oncological patients - CELL recommendations2020 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine